FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely psychiatry, and may be used for choosing a therapeutic approach to psychopharmacotherapy resistant schizophrenia. For this purpose, after pharmacoresistance has been stated, total blood serotonine and daily dopamine excretion are examined. If observing the reduction of serotonin and standard or low dopamine excretion, a course of electric electroconvulsive therapy is applied. High dopamine excretion regardless of the serotonin content, a course of electric electroconvulsive therapy is applied. In the other cases, family psychotherapy is used. The patient is treated with underlying supporting psychopharmacotherapy. At the same time, electric electroconvulsive and insulin-comatose therapy is contraindicated in case of active, decompensated physical and neurological diseases.
EFFECT: method provides the higher clinical effectiveness in the treatment-resistant patients with individual pathogenic direction of the therapeutic effect.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING COMPUTER DEPENDENCY | 2012 |
|
RU2486924C1 |
METHOD OF SHIZOPHRENIA THERAPY | 2008 |
|
RU2371209C1 |
METHOD OF TREATING PSYCOPHARMACOTHERAPY-RESISTANT SCHIZOPHRENIA | 2009 |
|
RU2412720C1 |
METHOD OF TREATING ALCOHOLISM AND/OR DRUG ADDICTION | 2008 |
|
RU2389515C1 |
USE OF ELECTROCONVULSIVE THERAPY FOR TREATMENT OF EXCESSIVE GAMBLING | 2007 |
|
RU2361630C2 |
SCHIZOPHRENIA THERAPY | 2008 |
|
RU2367479C1 |
METHOD FOR TREATMENT OF GAMBLING FIX | 2006 |
|
RU2339411C2 |
METHOD FOR TREATING RESISTANT FORMS OF ADDICTION SYNDROME (ALCOHOLISM, NARCOMANIAS, TOXICOMANIAS, GAMBLING, ETC.) AT ENDOGENOUS, RESIDUALLY ORGANIC, COMORBID DISORDERS AND PSYCHOSOMATIC COMPLICATIONS) | 2005 |
|
RU2301685C1 |
METHOD OF TREATING PATIENTS WITH BORDERLINE NEUROPSYCHIC PATHOLOGY | 2019 |
|
RU2691512C1 |
METHOD FOR SELECTING THERAPEUTIC APPROACH TO CHRONIC PELVIC PAIN SYNDROME TREATMENT | 2018 |
|
RU2692644C1 |
Authors
Dates
2013-10-20—Published
2012-04-26—Filed